Summer 2021 - Triform Sciences Marks 2-year Anniversary
Triform Sciences is pleased to have reached its two-year mark consulting in pharmaceutical development. I’ve had the opportunity to work on a variety of projects, including:
Writing P200 and development report for a commercial animal health product Working with two niche CROs as a project consultant Solid form guidance for a small biotech CMC team and collaborating with their CRO for molecules in R to D transition. IND review on Solid State Issues for a small biotech with a complex hydrate form Expert Witness on a solid form patent claims suit. Lecturing on Hydrates and Solvates for University of Alberta, Dept.of Chemical & Materials Engineering (recorded link available by request)
If you or a contact of yours is in need of expert support on issues like the ones I’ve listed, please let me know and I can set up an introductory discussion:
Making a decision on salt selection Understanding and selecting polymorphs, co-crystals or their transformation issues Finding the right advanced Solid State characterization tools Determining and managing API particle size targets for oral dosage forms Formulation development strategy and risk assessments for fast clinical development Defining work packages and identifying high quality CROs to conduct early development Formulation development strategy and risk assessments for fast clinical manufacture Expert witness, consulting expert or CRO support for patent litigation
I’m looking forward to some interesting projects in the coming year! Enjoy the rest of summer!
2020 In Review
Triform Sciences was fortunate to be a consulting partner for several clients this past year. The contracts included reviewing solid form development work in preparation for a client’s IND filing, working with a small molecule developer and their partner CRO to provide input on form screening, characterization and selection for several Phase I IND candidates. I also worked with a client providing technical input and analysis for internal reports, supporting and editing a P200 section for an animal health NADA. I am grateful to my 2020 clients for their support and helping to make this inaugural year a success. I am also thankful to my friends and colleagues that have supported me in this new endeavor.
Fall Webinar and Crystal Panel
In the fall of 2020, Paul joined the Crystal Pharmatech Crystal Panel as part of their seminar series on “Selecting the Right API Form and Formulation.” In addition to participating in the initial kickoff panel discussion, he presented a webinar on “Tools and Strategies for De-risking Rapid Drug Substance and Drug Product Development.” Please contact me if you would like any additional details.